U.S. and European Union Osteoporosis Drugs Industry Dominated by Bisphosphonates

The U.S. osteoporosis drugs market will reach USD 9,105.2 million by 2030, growing at a CAGR of 4.90%. Similarly, the EU osteoporosis drugs market revenue will be USD 4,265.4 million by the end of this decade, with a 4.65% CAGR, as stated by P&S Intelligence.To learn more...

Read More